Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Austin Sasha Lu — Olema Pharmaceuticals, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Austin Sasha Lu

Austin Sasha Lu

VP of Finance and Controller at Olema Pharmaceuticals, Inc. · on record since Feb 17, 2026

Insider trading activity of Austin Sasha Lu

Transactions on record: 2; since Feb 17, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 17, 2026

Figures computed from official regulatory filings — methodology.

Companies where Austin Sasha Lu has traded

Olema Pharmaceuticals, Inc.2 tx · Feb 17, 2026

Track record of Austin Sasha Lu

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Austin Sasha Lu

Co-insiders of Austin Sasha Lu

Asefaw SenaiOlema Pharmaceuticals, Inc.
Bain Capital Life Sciences Fund IV, L.P.Olema Pharmaceuticals, Inc.
Bain Capital Life Sciences Investors, LLCOlema Pharmaceuticals, Inc.
Bain Capital Life Sciences IV General Partner, LLCOlema Pharmaceuticals, Inc.
Bain Capital Life Sciences Opportunities IV GP, LLCOlema Pharmaceuticals, Inc.
Bain Capital Life Sciences Opportunities IV, L.P.Olema Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BIOTECHNOLOGY VALUE FUND II LPOlema Pharmaceuticals, Inc.

BIOTECHNOLOGY VALUE FUND L POlema Pharmaceuticals, Inc.

Biotechnology Value Trading Fund OS LPOlema Pharmaceuticals, Inc.

Bohen SeanOlema Pharmaceuticals, Inc.

BUTITTA CYNTHIA MOlema Pharmaceuticals, Inc.

BVF GP HOLDINGS LLCOlema Pharmaceuticals, Inc.

BVF I GP LLCOlema Pharmaceuticals, Inc.

BVF II GP LLCOlema Pharmaceuticals, Inc.

BVF INC/ILOlema Pharmaceuticals, Inc.

BVF PARTNERS L P/ILOlema Pharmaceuticals, Inc.

BVF Partners OS Ltd.Olema Pharmaceuticals, Inc.

Chen BihuaOlema Pharmaceuticals, Inc.

CLARK IAN TOlema Pharmaceuticals, Inc.

Cormorant Asset Management, LPOlema Pharmaceuticals, Inc.

Cormorant Global Healthcare Master Fund, LPOlema Pharmaceuticals, Inc.

Cormorant Private Healthcare Fund III LPOlema Pharmaceuticals, Inc.

Cormorant Private Healthcare Fund II, LPOlema Pharmaceuticals, Inc.

Garland J. ScottOlema Pharmaceuticals, Inc.

Graham G. WalmsleyOlema Pharmaceuticals, Inc.

Harmon CyrusOlema Pharmaceuticals, Inc.

Horning SandraOlema Pharmaceuticals, Inc.

Horn KinneyOlema Pharmaceuticals, Inc.

Hrustanovic GorjanOlema Pharmaceuticals, Inc.

Kovacs Shane William CharlesOlema Pharmaceuticals, Inc.

Kushner Peter J.Olema Pharmaceuticals, Inc.

LAMPERT MARK NOlema Pharmaceuticals, Inc.

Larson YiOlema Pharmaceuticals, Inc.

MCCORMICK FRANKOlema Pharmaceuticals, Inc.

Mitchell ShawnteOlema Pharmaceuticals, Inc.

Moriarty John BOlema Pharmaceuticals, Inc.

Myles David C.Olema Pharmaceuticals, Inc.

Paradigm BioCapital Advisors GP LLCOlema Pharmaceuticals, Inc.

Paradigm Biocapital Advisors LPOlema Pharmaceuticals, Inc.

Paradigm BioCapital International Fund Ltd.Olema Pharmaceuticals, Inc.

Raman PrakashOlema Pharmaceuticals, Inc.

RAPPAPORT ANDREWOlema Pharmaceuticals, Inc.

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.Olema Pharmaceuticals, Inc.

Zojwalla NaseemOlema Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Olema Pharmaceuticals, Inc.	Feb 17, 2026	Award	11,700	0.00 USD	$0	SEC
Olema Pharmaceuticals, Inc.	Feb 17, 2026	AwardD	29,250	0.00 USD	$0	SEC